Short-term dexamethasone treatment inhibits vein graft thickening in hypercholesterolemic ApoE3Leiden transgenic mice  Abbey Schepers, MD, Nuno M.M. Pires,

Slides:



Advertisements
Similar presentations
Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice  Daniël Eefting,
Advertisements

Vein wall re-endothelialization after deep vein thrombosis is improved with low- molecular-weight heparin  Daria K. Moaveni, MD, Erin M. Lynch, MS, Cathy.
Inhibition of smooth muscle cell migration and neointima formation in vein grafts by overexpression of matrix metalloproteinase-3  Klaus Kallenbach, MD,
Decellularized vein as a potential scaffold for vascular tissue engineering  Patrick J Schaner, MD, Niels D Martin, MD, Thomas N Tulenko, PhD, Irving M.
Reduced hind limb ischemia-reperfusion injury in Toll-like receptor-4 mutant mice is associated with decreased neutrophil extracellular traps  Rahmi Oklu,
In vivo electroporation of constitutively expressed HIF-1α plasmid DNA improves neovascularization in a mouse model of limb ischemia  Geoffrey O. Ouma,
Yi-kuan Chen, MD, Xue-mei Jiang, MSc, Jian-ping Gong, MD 
Kathleen D. Gibson, MD, Brian L
Pharmacologic blockade and genetic deletion of androgen receptor attenuates aortic aneurysm formation  John P. Davis, MD, Morgan Salmon, PhD, Nicolas.
Kenneth M. DeSart, MD, Khayree Butler, MD, Kerri A
Antisense oligonucleotide to proto-oncogene c-myb inhibits the formation of intimal hyperplasia in experimental vein grafts  Gregory J. Fulton, MB, FRCSI,
Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production 
Chun-Yu Wong, MD, Margreet R. de Vries, BSc, Yang Wang, MD, Joost R
Pharmacologic inhibition of nitric oxide synthases and cyclooxygenases enhances intimal hyperplasia in balloon-injured rat carotid arteries  Jens W Fischer,
Lysyl oxidase expression in a rat model of arterial balloon injury
Pressure distention compared with pharmacologic relaxation in vein grafting upregulates matrix metalloproteinase-2 and -9  Ada W.Y. Chung, PhD, Pooja.
Effect of blocking platelet activation with AZD6140 on development of abdominal aortic aneurysm in a rat aneurysmal model  Jianping Dai, MD, PhD, Liliane.
The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling 
Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice  Daniël Eefting,
True extracranial carotid artery aneurysm in a child
Adenoviral-mediated expression of antisense RNA to basic fibroblast growth factor reduces tangential stress in arterialized vein grafts  Abigail K. Hanna,
Jeanwan Kang, MD, Hassan Albadawi, MD, Virendra I. Patel, MD, Thomas A
A novel function for cadherin 11/osteoblast-cadherin in vascular smooth muscle cells: Modulation of cell migration and proliferation  Thomas S. Monahan,
Controlled release of ascorbic acid from gelatin hydrogel attenuates abdominal aortic aneurysm formation in rat experimental abdominal aortic aneurysm.
Use of Brilliant Blue FCF during vein graft preparation inhibits intimal hyperplasia  Michael J. Osgood, MD, Kevin Sexton, MD, Igor Voskresensky, MD, Kyle.
Aromatase is required for female abdominal aortic aneurysm protection
Adenovirus-mediated intra-arterial delivery of cellular repressor of E1A-stimulated genes inhibits neointima formation in rabbits after balloon injury 
Increased connexin43 expression in human saphenous veins in culture is associated with intimal hyperplasia  Sébastien Déglise, MD, David Martin, MS, Hervé.
Decellularized vein as a potential scaffold for vascular tissue engineering  Patrick J Schaner, MD, Niels D Martin, MD, Thomas N Tulenko, PhD, Irving M.
In situ localization and quantification of seventy-two – kilodalton type IV collagenase in aneurysmal, occlusive, and normal aorta  William D. McMillan,
Murine abdominal aortic aneurysm model by orthotopic allograft transplantation of elastase-treated abdominal aorta  Zhenjie Liu, MD, PhD, Qiwei Wang,
Tissue factor pathway inhibitor-2 is induced by fluid shear stress in vascular smooth muscle cells and affects cell proliferation and survival  Johan.
S-phase kinase-associated protein-2 (Skp2) promotes vascular smooth muscle cell proliferation and neointima formation in vivo  Yih-Jer Wu, MD, PhD, Graciela.
Duplex ultrasound changes in the great saphenous vein after endosaphenous laser occlusion with 808-nm wavelength  Leonardo Corcos, MD, Sergio Dini, MD,
Antisense to transforming growth factor-β1 messenger RNA reduces vein graft intimal hyperplasia and monocyte chemotactic protein 1  Randal A. Wolff, PhD,
Midkine is expressed by infiltrating macrophages in in-stent restenosis in hypercholesterolemic rabbits  Hiroshi Narita, MD, Sen Chen, PhD, Kimihiro Komori,
Michael A. Golden, MD, Y. P. Tina Au, PhD, Richard D
Sarpogrelate hydrochloride reduced intimal hyperplasia in experimental rabbit vein graft  Akio Kodama, MD, Kimihiro Komori, MD, PhD, Keisuke Hattori, MD,
T-cell co-stimulation by CD28–CD80/86 and its negative regulator CTLA-4 strongly influence accelerated atherosclerosis development  M.M. Ewing, J.C. Karper,
Conformational stress and anastomotic hyperplasia
In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the.
Adventitial endothelial implants reduce matrix metalloproteinase-2 expression and increase luminal diameter in porcine arteriovenous grafts  Helen M.
Role of hemodynamic forces in the ex vivo arterialization of human saphenous veins  Xavier Berard, MD, PhD, Sébastien Déglise, MD, Florian Alonso, PhD,
Surgical marking pen dye inhibits saphenous vein cell proliferation and migration in saphenous vein graft tissue  Shinsuke Kikuchi, MD, Richard D. Kenagy,
Ruptured brachial artery aneurysm in a patient with type 1 neurofibromatosis  Makoto Emori, MD, Norifumi Naka, MD, PhD, Hiroshi Takami, MD, PhD, Taka-Aki.
Antisense basic fibroblast growth factor gene transfer reduces neointimal thickening after arterial injury  Abigail K. Hanna, MD, Jonathan C. Fox, MD,
The temporal relationship between the development of vein graft intimal hyperplasia and growth factor gene expression  John R. Hoch, MD, Vida K. Stark,
Marcel Scheinman, MD, Enrico Ascher, MD, Gabriel S
Holger Lawall, MD, Peter Bramlage, MD, PhD, Berthold Amann, MD 
Hepatocyte growth factor prevents intimal hyperplasia in rabbit carotid expanded polytetrafluoroethylene grafting  Masakazu Harada, MD, Hiroaki Takenaka,
Thrombolysis for experimental deep venous thrombosis maintains valvular competence and vasoreactivity  Jeffrey M. Rhodes, MD, Jae-Sung Cho, MD, Peter.
The role of short-term oxygen administration in the prevention of intimal hyperplasia  Charu Lata, MBBS, Derrick Green, MD, Jing Wan, MD, Sabita Roy, PhD,
Masson's tumor in the ulnar artery
Immunolocalization and temporal distribution of cytokine expression during the development of vein graft intimal hyperplasia in an experimental model 
Mark K. Hirko, MD, Joseph R. McShannic, MD, Steven P
Yehuda G. Wolf, MD, Lars M. Rasmussen, MD, Yoav Sherman, MD, Warner P
Julia Humphries, MSc, Catharine L
Inhibition of N-cadherin retards smooth muscle cell migration and intimal thickening via induction of apoptosis  Cressida A. Lyon, PhD, Evgenia Koutsouki,
Leptin, pre-existing vascular disease, and increased arteriovenous fistula maturation failure in dialysis patients  Jwa-Kyung Kim, MD, Sun Ryoung Choi,
Development of a spontaneously beating vein by cardiomyocyte transplantation in the wall of the inferior vena cava in a rat: A pilot study  Wangde Dai,
Free radical attenuation prevents thrombosis and enables photochemical inhibition of vein graft intimal hyperplasia  Giuseppe R Nigri, MD, PhD, Sylvie.
Vein interposition cuffs decrease the intimal hyperplastic response of polytetrafluoroethylene bypass grafts  Mark Kissin, MD, Nikhil Kansal, MD, Peter.
Human saphenous vein allograft bypass grafts: Immune response
Blockade of monocyte chemoattractant protein-1 by adenoviral gene transfer inhibits experimental vein graft neointimal formation  Hideki Tatewaki, MD,
Macrophage depletion reduces monocyte chemotactic protein-1 and transforming growth factor-β1 in healing rat vein grafts  Randal A Wolff, PhD, Jeffrey.
Controlled release of small interfering RNA targeting midkine attenuates intimal hyperplasia in vein grafts  Hiroshi Banno, MD, Yoshifumi Takei, PhD,
Activation of transglutaminase type 2 for aortic wall protection in a rat abdominal aortic aneurysm formation  Takashi Munezane, MD, Tomomi Hasegawa,
Differential transcriptional activation of matrix metalloproteinase-2 and membrane type-1 matrix metalloproteinase by experimental deep venous thrombosis.
Decreased venous thrombosis with an oral inhibitor of P selectin
Prevention of stenosis after vascular reconstruction: Pharmacologic control of intimal hyperplasia—A review  Alexander W. Clowes, MD, Michael A. Reidy,
Presentation transcript:

Short-term dexamethasone treatment inhibits vein graft thickening in hypercholesterolemic ApoE3Leiden transgenic mice  Abbey Schepers, MD, Nuno M.M. Pires, MSc, Daniel Eefting, MD, Margreet R. de Vries, BSc, J. Hajo van Bockel, MD, PhD, Paul H.A. Quax, PhD  Journal of Vascular Surgery  Volume 43, Issue 4, Pages 809-815 (April 2006) DOI: 10.1016/j.jvs.2005.11.019 Copyright © 2006 The Society for Vascular Surgery Terms and Conditions

Fig 1 Dexamethasone treatment (0.15 mg · kg−1 · d−1 in drinking water) reduces vein graft thickening in hypercholesterolemic ApoE3Leiden mice after 28 days of treatment. A, Quantification of vein graft thickening shows a reduction of 43% in the dexamethasone-treated animals as compared with controls (n = 6; ⁎P < .05), whereas no significant changes in luminal area were observed (B). C, Representative cross section; arrows indicate a thickened vessel wall (stain, hematoxylin-phloxin-saffron; original magnification, ×40). No differences were seen in the cellular composition of thickened grafts in either group, as determined by computer-assisted morphometric analysis. D, Alpha smooth muscle actin staining representing vascular smooth muscle cells. E, AIA31240 staining representing macrophages. n.s., Not significant; dexa, dexamethasone. Journal of Vascular Surgery 2006 43, 809-815DOI: (10.1016/j.jvs.2005.11.019) Copyright © 2006 The Society for Vascular Surgery Terms and Conditions

Fig 2 Effect of 7 days of dexamethasone treatment on vein graft thickening 28 days after surgery in hypercholesterolemic ApoE3Leiden mice. There was a significant inhibition of vein graft thickening in the 7-day-treated animals (A) when compared with controls (n = 6; ⁎P < .05). There was no significant difference in luminal area between groups (B). n.s., Not significant; dexa, dexamethasone. Journal of Vascular Surgery 2006 43, 809-815DOI: (10.1016/j.jvs.2005.11.019) Copyright © 2006 The Society for Vascular Surgery Terms and Conditions

Fig 3 Effect of dexamethasone treatment on the early messenger RNA (mRNA) expression of proinflammatory cytokines in injured vessels of ApoE3Leiden mice (n = 4 per group). The relative mRNA expression in time in the dexamethasone-treated group is depicted compared with mRNA expression the control group (expression in the control group was defined as 1; ⁎P < .05). MCP, Monocyte chemotactic protein; TNF, tumor necrosis factor; MIP, macrophage inflammatory protein; TLR, toll-like receptor. Journal of Vascular Surgery 2006 43, 809-815DOI: (10.1016/j.jvs.2005.11.019) Copyright © 2006 The Society for Vascular Surgery Terms and Conditions

Fig 4 Effect of either short-term (D7d) or prolonged (D28d) dexamethasone exposure (0.75 mg/mL of medium) in intimal hyperplasia formation in human saphenous vein organ cultures (n = 12 per group). In both dexamethasone-exposed groups, a significantly decreased amount of intimal hyperplasia was seen when compared with the control segments (⁎P < .05; original magnification, ×100; dotted line indicates the border separating media from intima). n.s., Not significant. Journal of Vascular Surgery 2006 43, 809-815DOI: (10.1016/j.jvs.2005.11.019) Copyright © 2006 The Society for Vascular Surgery Terms and Conditions